Anna Shevchenko

Anna Shevchenko

Auto-generated profile, based on publicly available information

Anna Shevchenko

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2025 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
PMPatrick M. McCall
Patrick M. McCall
KKKyoohyun Kim
Kyoohyun Kim
ASAnna Shevchenko
Anna Shevchenko
MRMartine Ruer-Gruß
Martine Ruer-Gruß
JPJan Peychl
Jan Peychl
JBJan Brugués
Jan Brugués
Many subcellular compartments are biomolecular condensates made of multiple components, often including several distinct proteins and nucleic acids. However, current tools to measure condensate composition are limited and cannot capture this complexity quantitatively because they either require fluorescent labels, which can perturb composition, or can distinguish only one or two components. Here we describe a label-free method based on quantitative phase imaging and analysis of tie-lines and refractive index to measure the composition of reconstituted condensates with multiple components. We first validate the method empirically in binary mixtures, revealing sequence-encoded density variation and complex ageing dynamics for condensates composed of full-length proteins. We then use analysis of tie-lines and refractive index to simultaneously resolve the concentrations of five macromolecular solutes in multicomponent condensates containing RNA and constructs of multiple RNA-binding proteins. Our measurements reveal an unexpected decoupling of density and composition, highlighting the need to determine molecular stoichiometry in multicomponent condensates. We foresee this approach enabling the study of compositional regulation of condensate properties and function.

31 January 2025 in Science
Verified
Journal Article
Closed access
MYMax Dongsheng Yin
Max Dongsheng Yin
OLOlivier Nicolas Lemaire
Olivier Nicolas Lemaire
JJJosé Guadalupe Rosas Jiménez
José Guadalupe Rosas Jiménez
MBMélissa Belhamri
Mélissa Belhamri
ASAnna Shevchenko
Anna Shevchenko
BMBonnie J. Murphy
Bonnie J. Murphy
In the ancient microbial Wood-Ljungdahl pathway, carbon dioxide (CO 2 ) is fixed in a multistep process that ends with acetyl–coenzyme A (acetyl-CoA) synthesis at the bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase complex (CODH/ACS). In this work, we present structural snapshots of the CODH/ACS from the gas-converting acetogen Clostridium autoethanogenum , characterizing the molecular choreography of the overall reaction, including electron transfer to the CODH for CO 2 reduction, methyl transfer from the corrinoid iron-sulfur protein (CoFeSP) partner to the ACS active site, and acetyl-CoA production. Unlike CODH, the multidomain ACS undergoes large conformational changes to form an internal connection to the CODH active site, accommodate the CoFeSP for methyl transfer, and protect the reaction intermediates. Altogether, the structures allow us to draw a detailed reaction mechanism of this enzyme, which is crucial for CO 2 fixation in anaerobic organisms.

26 February 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JMJoshua Mills
Joshua Mills
LGLaura Johanna Gebhard
Laura Johanna Gebhard
FSFlorence Schubotz
Florence Schubotz
ASAnna Shevchenko
Anna Shevchenko
DSDaan R. Speth
Daan R. Speth
SESusanne Erdmann
Susanne Erdmann
Since their discovery, extracellular vesicles (EVs) have changed our view on how organisms interact with their extracellular world. EVs are able to traffic a diverse array of molecules across different species and even domains, facilitating numerous functions. In this study, we investigate EV production in Euryarchaeota, using the model organism Haloferax volcanii . We uncover that EVs enclose RNA, with specific transcripts preferentially enriched, including those with regulatory potential, and conclude that EVs can act as an RNA communication system between haloarchaea. We demonstrate the key role of an EV-associated small GTPase for EV formation in H. volcanii that is also present across other diverse evolutionary branches of Archaea. We propose the name, ArvA, for the identified family of archaeal vesiculating GTPases. Additionally, we show that two genes in the same operon with arvA ( arvB and arvC ) are also involved in EV formation. Both, arvB and arvC , are closely associated with arvA in the majority of other archaea encoding ArvA. Our work demonstrates that small GTPases involved in membrane deformation and vesiculation, ubiquitous in Eukaryotes, are also present in Archaea and are widely distributed across diverse archaeal phyla.

17 December 2025 in Nature
Verified
Journal Article
Open access
PDF file
LYLei Yuan
Lei Yuan
SDSagarika Dawka
Sagarika Dawka
YKYohan Kim
Yohan Kim
ALAnke Liebert
Anke Liebert
FRFabian Rost
Fabian Rost
MHMeritxell Huch
Meritxell Huch
The development of complex multicellular human in vitro systems holds great promise for modelling disease and advancing drug discovery and tissue engineering 1 . In the liver, despite the identification of key signalling pathways involved in hepatic regeneration 2,3 , in vitro expansion of human hepatocytes directly from fresh patient tissue has not yet been achieved, limiting the possibility of modelling liver composite structures in vitro. Here we first developed human hepatocyte organoids (h-HepOrgs) from 28 different patients. Patient-derived hepatocyte organoids sustained long-term expansion of hepatocytes in vitro and maintained patient-specific gene expression and bile canaliculus features and function of the in vivo tissue. After transplantation, expanded h-HepOrgs rescued the phenotype of a mouse model of liver disease. By combining h-HepOrgs with portal mesenchyme and our previously published cholangiocyte organoids 4–6 , we generated patient-specific periportal liver assembloids that retain the histological arrangement, gene expression and cell interactions of periportal liver tissue, with cholangiocytes and mesenchyme embedded in the hepatocyte parenchyma. We leveraged this platform to model aspects of biliary fibrosis. Our human periportal liver assembloid system represents a novel in vitro platform to investigate human liver pathophysiology, accelerate drug development, enable early diagnosis and advance personalized medicine.

29 October 2025 in Nature Chemical Biology
Verified
Journal Article
Open access
PDF file
OLOlivier Nicolas Lemaire
Olivier Nicolas Lemaire
MBMélissa Belhamri
Mélissa Belhamri
ASAnna Shevchenko
Anna Shevchenko
TWTristan Wagner
Tristan Wagner
Microbial alcohol production from waste gases is a game changer for sustainable carbon cycling and remediation. While the biotechnological process using Clostridium autoethanogenum to transform syngas (H 2 , CO 2 and CO) is blooming, scientific debates remain on the ethanol biosynthesis pathway. Here, we experimentally validated that ethanol production is initiated through a tungsten-dependent aldehyde:ferredoxin oxidoreductase (AFOR), which reduces acetate to acetaldehyde. The reaction, thermodynamically unfavorable under standard conditions, has been considered by many as unsuitable in vivo but is rather approved by metabolic modeling. To answer this riddle, we demonstrated that the thermodynamic coupling of CO oxidation and ethanol synthesis allows acetate reduction. The experiments, performed with native CO dehydrogenase and AFOR, highlighted the key role of ferredoxin in stimulating the activity of both metalloenzymes and electron shuttling. The crystal structure of holo AFOR, refined to 1.59-Å resolution, and its biochemical characterization provide new insights into the cofactor chemistry and the specificities of this enzyme, fundamental to sustainable biofuel production.

17 September 2025 in Research Square
Verified
Preprint
Open access
PDF file
MHMeritxell Huch
Meritxell Huch
LYLei Yuan
Lei Yuan
ALAnke Liebert
Anke Liebert
SDSagarika Dawka
Sagarika Dawka
RARobert Arnes-Benito
Robert Arnes-Benito
DCDongho Choi
Dongho Choi
The development of complex multicellular human in vitro systems holds great promise for modelling disease and progressing drug discovery and tissue engineering 1 . In the liver, despite the identification of key signalling pathways involved in hepatic regeneration 2,3 , in vitro expansion of human hepatocytes directly from fresh patient tissue has not yet been achieved, limiting the possibility of modelling liver composite structures in vitro . Here, we first developed human hepatocyte organoids (h-HepOrgs) from 28 different patients. Patient-derived hepatocyte organoids sustain long-term expansion of hepatocytes in vitro and maintain patient-specific gene expression, and bile canaliculi features and function of the in vivo tissue. After transplantation, expanded human hepatocyte organoids rescue the phenotype of a mouse model of liver disease. By combining human hepatocyte organoids with portal mesenchyme and our previously published cholangiocyte organoids 4-6 , we generated patient-specific periportal liver assembloids that retain the histological arrangement, gene expression and cell interactions of the periportal liver tissue, with cholangiocytes and mesenchyme embedded in the hepatocyte parenchyma. We leveraged this platform to model aspects of biliary fibrosis. Our human periportal liver assembloid system represents a novel in vitro platform to investigate human liver pathophysiology, accelerate drug development, enable early diagnosis and progress personalized medicine.